DK708088A - Farmaceutisk praeparat med forlaenget frigivelsestid - Google Patents

Farmaceutisk praeparat med forlaenget frigivelsestid

Info

Publication number
DK708088A
DK708088A DK708088A DK708088A DK708088A DK 708088 A DK708088 A DK 708088A DK 708088 A DK708088 A DK 708088A DK 708088 A DK708088 A DK 708088A DK 708088 A DK708088 A DK 708088A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
extended release
release time
extended
time
Prior art date
Application number
DK708088A
Other languages
English (en)
Other versions
DK172370B1 (da
DK708088D0 (da
Inventor
Howard Stevens
Maryvonne Chariot
Francoise Arnold
Gareth Lewis
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK708088D0 publication Critical patent/DK708088D0/da
Publication of DK708088A publication Critical patent/DK708088A/da
Application granted granted Critical
Publication of DK172370B1 publication Critical patent/DK172370B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK708088A 1987-12-21 1988-12-20 Farmaceutisk præparat med forlænget frigivelsestid DK172370B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8717855A FR2624732B1 (fr) 1987-12-21 1987-12-21 Formulation pharmaceutique a liberation prolongee
FR8717855 1987-12-21

Publications (3)

Publication Number Publication Date
DK708088D0 DK708088D0 (da) 1988-12-20
DK708088A true DK708088A (da) 1989-06-29
DK172370B1 DK172370B1 (da) 1998-04-27

Family

ID=9358116

Family Applications (1)

Application Number Title Priority Date Filing Date
DK708088A DK172370B1 (da) 1987-12-21 1988-12-20 Farmaceutisk præparat med forlænget frigivelsestid

Country Status (23)

Country Link
US (1) US5112621A (da)
EP (1) EP0322277B1 (da)
JP (1) JPH082782B2 (da)
KR (1) KR960009650B1 (da)
AR (1) AR243378A1 (da)
AT (1) ATE71837T1 (da)
AU (1) AU609916B2 (da)
CA (1) CA1332567C (da)
DE (1) DE3868037D1 (da)
DK (1) DK172370B1 (da)
ES (1) ES2051881T3 (da)
FI (1) FI97445C (da)
FR (1) FR2624732B1 (da)
GR (1) GR3003826T3 (da)
HU (1) HU199685B (da)
IE (1) IE60313B1 (da)
IL (1) IL88736A (da)
IT (1) IT8723196A0 (da)
MX (1) MX169322B (da)
NO (1) NO179357C (da)
NZ (1) NZ227412A (da)
PT (1) PT89276B (da)
ZA (1) ZA889495B (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
CA2137265C (en) * 1992-06-04 2003-10-28 Sanjay Bhardwaj Palatable pharmaceutical compositions
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
JP3264722B2 (ja) * 1993-02-25 2002-03-11 第一製薬株式会社 カプセル製剤
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
KR100440553B1 (ko) * 1998-03-26 2004-07-15 후지사와 야꾸힝 고교 가부시키가이샤 서방성 제제
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US6663896B1 (en) 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
KR100407519B1 (ko) * 2001-08-31 2003-12-18 부광약품 주식회사 건조황산제일철과 방출조절제로서 엘-글루타민을 함유하는서방성 정제 및 그의 제조방법
KR100446818B1 (ko) * 2001-11-06 2004-09-01 김재윤 질산 이소소르비드 서방성 펠렛 제형
PE20050484A1 (es) 2003-10-29 2005-10-13 Wyeth Corp Composicion farmaceutica de liberacion sostenida
EP1730516A1 (en) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Method and device for evaluation of pharmaceutical compositions
KR100775957B1 (ko) * 2006-02-07 2007-11-13 경상대학교산학협력단 애기장대 유래의 개화시기를 조절 단백질 ｃｏ의 돌연변이단백질, 상기 단백질을 이용한 식물의 개화시기 조절전사인자의 분리방법 및 식물의 개화시기 조절방법
CN100442981C (zh) * 2006-11-09 2008-12-17 广东省昆虫研究所 一种德国小蠊毒饵
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8974827B2 (en) * 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
EP2231169B1 (en) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2550863A1 (de) * 2011-07-27 2013-01-30 Bayer Intellectual Property GmbH Aktivstoffhaltige Partikel auf Polyacrylat-Basis
DK2970101T3 (da) 2013-03-14 2018-08-20 Alkermes Pharma Ireland Ltd Pro-drugs af fumarater og deres anvendelse i behandling af forskellige sygdomme
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
KR101639163B1 (ko) * 2015-07-08 2016-07-22 울산대학교 산학협력단 저전송 영상 정보 및 센싱 정보 송수신 장치 및 이의 동작 방법
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
JPS625915A (ja) * 1985-07-03 1987-01-12 Nippon Iyakuhin Kogyo Kk 塩酸ジルチアゼム徐放性製剤及びその製法
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
NO179357C (no) 1996-09-25
DK172370B1 (da) 1998-04-27
IE883810L (en) 1989-06-21
PT89276A (pt) 1989-12-29
AU2707788A (en) 1989-06-22
FI97445B (fi) 1996-09-13
IL88736A (en) 1992-11-15
EP0322277B1 (fr) 1992-01-22
JPH082782B2 (ja) 1996-01-17
FR2624732B1 (fr) 1991-02-15
ATE71837T1 (de) 1992-02-15
KR890009380A (ko) 1989-08-01
DE3868037D1 (de) 1992-03-05
ES2051881T3 (es) 1994-07-01
AR243378A1 (es) 1993-08-31
HUT49290A (en) 1989-09-28
NO885641L (no) 1989-06-22
PT89276B (pt) 1993-12-31
IL88736A0 (en) 1989-07-31
NO179357B (no) 1996-06-17
NZ227412A (en) 1989-12-21
NO885641D0 (no) 1988-12-20
MX169322B (es) 1993-06-29
KR960009650B1 (en) 1996-07-23
IE60313B1 (en) 1994-06-29
FI97445C (fi) 1996-12-27
JPH02202A (ja) 1990-01-05
FR2624732A1 (fr) 1989-06-23
ZA889495B (en) 1989-09-27
US5112621A (en) 1992-05-12
GR3003826T3 (da) 1993-03-16
DK708088D0 (da) 1988-12-20
CA1332567C (en) 1994-10-18
AU609916B2 (en) 1991-05-09
FI885884A0 (fi) 1988-12-20
FI885884A (fi) 1989-06-22
EP0322277A1 (fr) 1989-06-28
HU199685B (en) 1990-03-28
IT8723196A0 (it) 1987-12-23

Similar Documents

Publication Publication Date Title
DK708088D0 (da) Farmaceutisk praeparat med forlaenget frigivelsestid
DK89090D0 (da) Farmaceutisk praeparat
DK686187D0 (da) Veterinaert praeparat
SE8801813D0 (sv) Pharmaceutical composition
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
KR890701101A (ko) 제약학적 조성물
IS3339A7 (is) Ný efnablanda lyfja
DK100488D0 (da) Farmaceutisk plaster
DK130287D0 (da) Oralt praeparat
DK489189A (da) Farmaceutisk praeparat
DK705488D0 (da) Farmaceutisk praeparat
DK435688D0 (da) Farmaceutiske midler
DK603988D0 (da) Farmaceutisk praeparat
DK250088D0 (da) Ophthalmologisk praeparat
DK336489D0 (da) Farmaceutisk praeparat
DK139388A (da) Farmaceutisk praeparat
DK276288D0 (da) Farmaceutisk praeparat
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK138888D0 (da) Farmaceutisk praeparat
DK662587A (da) Herbicidt praeparat
DK638889A (da) Farmaceutisk kombinationspraeparat
DK560689A (da) Langsomt frigoerende farmaceutisk praeparat fremstillet med alginsyre
DK428287A (da) Nasalt farmaceutisk praeparat
DK477487D0 (da) Praeparat
BR6702689U (pt) Colher medicinal

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired